Literature DB >> 19149617

The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (Patho)-physiology, rationale and perspective on pulse pressure amplification.

Athanassios D Protogerou1, Theodore G Papaioannou, John P Lekakis, Jacques Blacher, Michel E Safar.   

Abstract

The blood pressure (BP) waveform varies substantially between the peripheral conduit (brachial) and the central elastic (aorta) arteries mainly do a gradual increase of systolic BP, as the wave propagates distally. This phenomenon is called BP amplification and is principally generated by the presence of arterial stiffness gradient and wave reflections along the arterial bed. More and more clinical studies suggest that central BP may provide additional information regarding cardiovascular risk beyond peripheral BP. Arterial properties and thus pressure amplification, are modulated by age, cardiovascular risk factors, vasoactive substances and drugs. Recent evidence suggests, beyond any doubt, that antihypertensive drugs affect peripheral and central BP differentially and alter pressure amplification. In the present review (Part I) we deal with the mechanisms underlying: (i) the genesis and recording of BP difference between central and peripheral arteries (pressure amplification), (ii) the rational of differential effect of antihypertensive drugs on pressure amplification, (iii) the pathophysiological role of pressure amplification on cardiovascular disease as well as its clinical and research implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149617     DOI: 10.2174/138161209787354267

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

Review 1.  Pharmacological modulation of arterial stiffness.

Authors:  Pierre Boutouyrie; Patrick Lacolley; Marie Briet; Véronique Regnault; Alice Stanton; Stéphane Laurent; Azra Mahmud
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

2.  Practical Suitability of a Stand-Alone Oscillometric Central Blood Pressure Monitor: A Review of the Microlife WatchBP Office Central.

Authors:  Willem J Verberk; Hao-Min Cheng; Li-Chih Huang; Chia-Ming Lin; Yao-Pin Teng; Chen-Huan Chen
Journal:  Pulse (Basel)       Date:  2016-02-12

3.  Effect of supine versus sitting position on noninvasive assessment of aortic pressure waveform: a randomized cross-over study.

Authors:  D Vrachatis; T G Papaioannou; A Konstantopoulou; E G Nasothimiou; S Millasseau; J Blacher; M E Safar; P P Sfikakis; G S Stergiou; A D Protogerou
Journal:  J Hum Hypertens       Date:  2013-10-24       Impact factor: 3.012

4.  High pulse pressure is not associated with abnormal activation of the renin-angiotensin-aldosterone system in repaired aortic coarctation.

Authors:  T A L Pedersen; E B Pedersen; K Munk; V E Hjortdal; K Emmertsen; N H Andersen
Journal:  J Hum Hypertens       Date:  2014-08-28       Impact factor: 3.012

5.  Central Blood Pressure Waves Assessment: A Validation Study of Non-invasive Aortic Pressure Measurement in Human Beings.

Authors:  Ramiro Sánchez; Franco Pessana; Gabriel Lev; Micaela Mirada; Oscar Mendiz; Agustín Ramírez; Edmundo Cabrera Fischer
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-25

6.  Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association.

Authors:  Raymond R Townsend; Ian B Wilkinson; Ernesto L Schiffrin; Alberto P Avolio; Julio A Chirinos; John R Cockcroft; Kevin S Heffernan; Edward G Lakatta; Carmel M McEniery; Gary F Mitchell; Samer S Najjar; Wilmer W Nichols; Elaine M Urbina; Thomas Weber
Journal:  Hypertension       Date:  2015-07-09       Impact factor: 10.190

7.  Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness.

Authors:  Francesca Kum; Janaka Karalliedde
Journal:  Integr Blood Press Control       Date:  2010-06-04

8.  Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease--a randomized trial.

Authors:  Marie Frimodt-Møller; Anne-Lise Kamper; Svend Strandgaard; Svend Kreiner; Arne Høj Nielsen
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

Review 9.  Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization.

Authors:  James E Sharman; Alberto P Avolio; Johannes Baulmann; Athanase Benetos; Jacques Blacher; C Leigh Blizzard; Pierre Boutouyrie; Chen-Huan Chen; Phil Chowienczyk; John R Cockcroft; J Kennedy Cruickshank; Isabel Ferreira; Lorenzo Ghiadoni; Alun Hughes; Piotr Jankowski; Stephane Laurent; Barry J McDonnell; Carmel McEniery; Sandrine C Millasseau; Theodoros G Papaioannou; Gianfranco Parati; Jeong Bae Park; Athanase D Protogerou; Mary J Roman; Giuseppe Schillaci; Patrick Segers; George S Stergiou; Hirofumi Tomiyama; Raymond R Townsend; Luc M Van Bortel; Jiguang Wang; Siegfried Wassertheurer; Thomas Weber; Ian B Wilkinson; Charalambos Vlachopoulos
Journal:  Eur Heart J       Date:  2017-10-01       Impact factor: 29.983

10.  Prevalence and real-world assessment of central aortic blood pressure in adult patients with essential hypertension uncontrolled on single anti-hypertensive agents.

Authors:  Ranjan Kumar Sharma; Manish Verma; Ravi M Tiwari; Abhay Joshi; Chirag A Trivedi; Deepa R Chodankar
Journal:  Indian Heart J       Date:  2018-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.